戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 19019作成日:2026年10月24日

Diisopropylethylamine → (S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amide

https://huagongshe.com/ja/reaction/19019

反応式

関与物質

役割名称HCID仕込み量
反応物DiisopropylethylamineHCID 81531—
反応物Benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphateHCID 151348—
反応物(S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acidHCID 66894832—
反応物HMS5552 HClHCID 66899094—
溶媒DimethylformamideHCID 6228—
溶媒Ethyl AcetateHCID 8857—
生成物(S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amideHCID 57920168—

反応条件

温度25 °C

反応手順

A solution of (S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid (130 mg, 0.4 mmol) in N,N-dimethylformamide (4 mL) was treated with 1-(3-amino-pyrazol-1-yl)-2-methyl-propan-2-ol (prepared in U.S. Pat. Appl. US2008021032 Example 80, 75 mg, 0.46 mmol), benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (353 mg, 0.8 mmol) and N,N-diisopropylethylamine (103 mg, 0.8 mmol). The reaction mixture was stirred for 4 h at 25° C., under nitrogen. The reaction mixture was diluted with ethyl acetate, washed with saturated ammonium chloride, water, a saturated sodium chloride solution and dried over sodium sulfate. The organic layer was concentrated, and the crude product was purified by ISCO flash chromatography (Teledyne Isco RediSep Flash Column 12 g, 30% to 100% ethyl acetate/hexanes) to afford (S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amide as a fluffy material. This material was dissolved in diethyl ether (4 mL) and treated with hydrogen chloride in diethyl ether (1 M, 4 mL). Solvents were evaporated and the residue was triturated with diethyl ether. The solid was filtered to give (S)-2-[4-(2-ethoxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amide hydrochloride (45 mg, 23%): HR-ES-MS m/z calculated for C25H34N4O5 [M+H]+ 471.2602, observed 471.2603; 1H NMR (300 MHz, DMSO-d6) δ ppm 0.89 (d, J=6.6 Hz, 3H), 0.92 (d, J=6.6 Hz, 3H), 1.04 (br. s., 3H), 1.06 (br. s., 3H), 1.26 (t, J=6.8 Hz, 3H), 1.32-1.64 (m, 2H), 1.64-1.82 (m, 1H), 3.89 (s, 2H), 4.00-4.13 (m, 3H), 4.35-4.62 (m, 2H), 4.74 (s, 1H), 4.89 (dd, J=10.9, 4.5 Hz, 1H), 6.43 (d, J=2.1 Hz, 1H), 6.99 (t, J=6.9 Hz, 1H), 7.15-7.22 (m, 1H), 7.22-7.32 (m, 2H), 7.53 (d, J=2.1 Hz, 1H), 10.77 (s, 1H).

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US07741327B2
出典データセットuspto-grants-2010_06
ORD IDord-3ff13002eefc4cf0b0deb0c0ac6fad2d
出典メモuspto-grants-2010_06